Health ❯Healthcare ❯Patient Safety

Medication Risks

Long-term Use Side Effects Unregulated Products Unregulated Retailers Online Drug Purchases Unlicensed Drugs Ocular Side Effects Obesity Management Adverse Effects Long-term Use Risks Long-term Use of Opioids Hormonal Medications Health Alerts Prescription Medications Personalized Medicine Contraindications Gender Differences in Treatment

Anvisa Approves Dayvigo (Lemborexant) for Adult Insomnia in Brazil

The orexin‑blocking medicine won authorization based on evidence of strong efficacy and a lower dependence risk than traditional hypnotics.

New Trials Challenge Routine Beta-Blocker Use After Heart Attack, With Possible Harm in Women

Spain Urges Caution After REBOOT Trial Finds No Routine Benefit From Beta-Blockers Post-MI

Danish Study Finds No Link Between Vaginal Estrogen Tablets and Recurrent Ischemic Stroke

FDA Mandates Opioid Label Overhaul to Quantify Long-Term Risks

Long-Term Desogestrel Use Linked to Slight Rise in Brain Tumor Risk

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

Pharmacists Warn Against Unlicensed Kenalog for Hay Fever Amid Surge in Demand

Warnings Issued Over Unsafe Online Sales of Weight-Loss Injections

Ozempic Linked to Rare Eye Condition, EU to Investigate

France Restricts Sale of Eight Popular Cold Medications Over Safety Concerns